SCHEDULE: Glazer Capital Discloses 6.45% Stake in Vigil Neuroscience

Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of 6.45% of Vigil Neuroscience, Inc.'s common stock.

Summary

• Glazer Capital, LLC and Paul J. Glazer are the reporting persons.
• They collectively beneficially own 3,012,068 shares of Vigil Neuroscience, Inc. Common Stock.
• This ownership represents 6.45% of the class of securities.
• The shares are held by certain funds and managed accounts for which Glazer Capital serves as investment manager.
• Paul J. Glazer serves as the Managing Member of Glazer Capital.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a previous filing of beneficial ownership.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership and does not contain information that would indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment in Vigil Neuroscience, Inc., a company likely operating in the biotechnology or pharmaceutical sector given its name and the nature of institutional investment in such firms.

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional stake can influence market perception and potentially signal confidence or interest from large investors.

Key Dates

Keywords

Vigil Neuroscience, Glazer Capital, Paul J. Glazer, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor